CD4 and neoplasm: Several studies have shown that high densities of tumor-infiltrating lymphocytes (TILs)—such as CD3+TILs, CD4+TILs, CD8+TILs and CD20+TILs – are favorable prognostic biomarkers17,22,69–71.